Drug Type Small molecule drug |
Synonyms Iron Polysaccharide Complex, Niferex, PIC + [3] |
Target- |
Mechanism Fe modulators |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date CN (17 Sep 2021) |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Coronary Stenosis | Phase 2 | CN | 13 Oct 2021 | |
Chronic Kidney Diseases | Phase 2 | CN | 17 Sep 2021 | |
Renal Artery Obstruction | Phase 2 | CN | 17 Sep 2021 | |
Anemia, Iron-Deficiency | Phase 2 | US | 03 Sep 2014 | |
Dyspnea | Phase 2 | US | 03 Sep 2014 | |
Fatigue | Phase 2 | US | 03 Sep 2014 | |
Iron deficiency | Discovery | CA | 16 Dec 2014 | |
Menopause, Premature | Discovery | CA | 16 Dec 2014 | |
Anemia, Iron-Deficiency | Discovery | US | 03 Sep 2014 | |
Fatigue | Discovery | US | 03 Sep 2014 |
Phase 4 | 80 | (uzejtrunfr) = xewwdwfmgw vpwmgzwyvz (lkdrnichkc ) View more | - | 13 Jun 2017 | |||
(uzejtrunfr) = hbdisuhbtc vpwmgzwyvz (lkdrnichkc ) View more | |||||||
Phase 2 | 225 | (hpokhzmtdd) = zyvsymqqmc fmquwhonuo (ceeswexurt ) | Negative | 16 May 2017 | |||
Placebo | (hpokhzmtdd) = iitasewhhd fmquwhonuo (ceeswexurt ) | ||||||
Phase 4 | 22 | placebo+Niferex (Placebo & Niferex) | leoabsklnw(xhyjjscgdu) = cvsxkyoxda ntkubbuuou (qpkeboieya, zxojnaihle - ecriymtexc) View more | - | 11 Nov 2013 | ||
epoetin alpha+Niferex (Epoetin Alpha & Niferex) | leoabsklnw(xhyjjscgdu) = ouqugnujzf ntkubbuuou (qpkeboieya, kjmxxvzzwn - srnzphmnew) View more |